Quest wraps up $300M unit sale; Medical device alarms could distract docs, harm patients;

 @FierceMedDev: Report: Device tax is hard to decipher and kills jobs. More | Follow @FierceMedDev

 @MarkHFierce: Med device VC continues to be steady for late stage companies. iRhythm pulled in a $16M Series D. Release | Follow @MarkHFierce

 @DamianFierce: St. Jude won EU approval to treat dystonia with its deep-brain simulators. News | Follow @DamianFierce

> Quest Diagnostics ($DGX) has closed its $300 million sale of the HemoCue business to Danaher's ($DHR) Radiometer Medical unit. News

> Hospital workers are so desensitized by constantly beeping alarms from devices that monitor critically ill patients that they often ignore the noise and some patients die as a result. Story

> Insight Product Development in Chicago is launching Insight Labs, an accelerator program for budding medical device companies. Story

> Devicemaker Andain has completed all the tests required to secure FDA clearance for its miniature disposable insulin pump. More

> Baylor Health Care System in Dallas, Dignity Health in San Francisco and insurance giant United Healthcare formed a group that monitors effectiveness of devices including hip implants, heart valves and stents. Story

> Advanced Animal Diagnostics closed a $6 million Series B financing tranche from Intersouth Partners, Novartis Venture Funds and private investors. Release

> The Twin Cities remains a top-10 hub for med tech companies, according to a new report. Article

Biotech News

 @FierceBiotech: Trending: Groton throws up a new hurdle to Pfizer's R&D demolition plan. Story | Follow @FierceBiotech

 @JohnCFierce: Fun list from Evaluate on the top 10 blockbuster busts in biopharma. List | Follow @JohnCFierce.

 @RyanMFierce: Started my day 2 here at BioIT13 with a story about Novartis' big decision on whether to buy Proteon in $550M deal. News | Follow @RyanMFierce

> VistaGen raises $36M for stem cell tech. More

> Amid cheers and jeers, GlaxoSmithKline reveals Duchenne drug hit primary PhII goal. Article

> FDA stokes blockbuster hopes with 'breakthrough' brand for Pfizer cancer drug. News

Pharma News

 @FiercePharma: Trending yesterday: U.S. adults still skipping pills to save money, CDC finds. Article | Follow @FiercePharma

 @EricPFierce: Drugmakers with plants in EU still sweating whether China, India will meet deadline for new API regulations. Report | Follow @EricPFierce

> Lilly settles long-running lawsuit tying Cymbalta to teen's suicide. Story

> Merck kept mum on Fosamax's fracture risks, trial lawyer says. Report

Drug Delivery News

 @MichaelGFierce: From SpringLeaf's ashes, scPharma continues with minipump delivery. Article | Follow @MichaelGFierce

> TissueGen launches Elute drug-delivering fiber. News

> 3-D printer makes synthetic tissue for drug delivery. Report

> Self-assembling cancer drugs deliver themselves. Item

> Ambrx's cancer antibody delivery tech wins Astellas partnership. More

> Nano-delivered cell gatekeepers can improve drug performance, study finds. Story

Suggested Articles

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.

The former CEO of the molecular testing company Foundation Medicine, Troy Cox, has been named chairman of the Swiss big data firm Sophia Genetics.

Researchers at MIT used a machine-learning algorithm to uncover the potent antibiotic properties hiding within an old small-molecule candidate.